ATE329589T1 - Multipartikuläre bisoprolol formulierung - Google Patents

Multipartikuläre bisoprolol formulierung

Info

Publication number
ATE329589T1
ATE329589T1 AT00900786T AT00900786T ATE329589T1 AT E329589 T1 ATE329589 T1 AT E329589T1 AT 00900786 T AT00900786 T AT 00900786T AT 00900786 T AT00900786 T AT 00900786T AT E329589 T1 ATE329589 T1 AT E329589T1
Authority
AT
Austria
Prior art keywords
bisoprolol
formulation
polymeric coating
multiparticular
bisoprolol formulation
Prior art date
Application number
AT00900786T
Other languages
English (en)
Inventor
Niall Fanning
Catherine Mary Kelly
Paul Stark
Original Assignee
Athpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE990048A external-priority patent/IE990048A1/en
Application filed by Athpharma Ltd filed Critical Athpharma Ltd
Application granted granted Critical
Publication of ATE329589T1 publication Critical patent/ATE329589T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00900786T 1999-01-21 2000-01-17 Multipartikuläre bisoprolol formulierung ATE329589T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11681999P 1999-01-21 1999-01-21
IE990048A IE990048A1 (en) 1999-01-21 1999-01-21 Multiparticulate bisoprolol formulation

Publications (1)

Publication Number Publication Date
ATE329589T1 true ATE329589T1 (de) 2006-07-15

Family

ID=26320236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00900786T ATE329589T1 (de) 1999-01-21 2000-01-17 Multipartikuläre bisoprolol formulierung

Country Status (8)

Country Link
EP (1) EP1143963B1 (de)
JP (1) JP2002535271A (de)
AT (1) ATE329589T1 (de)
AU (1) AU3071300A (de)
CA (1) CA2359709A1 (de)
DE (1) DE60028730T2 (de)
ES (1) ES2267491T3 (de)
WO (1) WO2000042998A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (de) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Geschmacksverdeckende pharmazeutische Zusammensetzungen mit magenlöslichen Porenbildnern
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
IES20070122A2 (en) * 2006-12-05 2008-05-28 Michael Hilary Burke A process for the preparation of an orally administered unit dose tablet
NZ600256A (en) 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same

Also Published As

Publication number Publication date
WO2000042998A1 (en) 2000-07-27
EP1143963B1 (de) 2006-06-14
DE60028730T2 (de) 2006-12-28
AU3071300A (en) 2000-08-07
CA2359709A1 (en) 2000-07-27
EP1143963A1 (de) 2001-10-17
ES2267491T3 (es) 2007-03-16
WO2000042998A9 (en) 2001-05-25
DE60028730D1 (de) 2006-07-27
JP2002535271A (ja) 2002-10-22

Similar Documents

Publication Publication Date Title
DE60028730D1 (de) Multipartikuläre bisoprolol formulierung
NZ509028A (en) Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film
WO2002028376A3 (en) Chrono delivery formulations and method of use thereof
PL356962A1 (en) Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
IL153086A0 (en) Oral pharmaceutical composition with controlled release and prolonged absorption
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
ES2180683T3 (es) Preparacion de nifedipina de liberacion con duracion prolongada.
MY126555A (en) Oral pharmaceutical extended release dosage form
WO2001076575A3 (en) The treatment of respiratory diseases
HK1031197A1 (en) Osmotic dosage form comprising first and second coats
HUP0201711A2 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
NO20013757D0 (no) Kjernetablett for kontrollert frigivelse av glicazid etter oral administrasjon
ATE286387T1 (de) Clarithromycin enthaltende zubereitung mit verlängerter freisetzung
WO2003005968A3 (en) Dual release levodopa ethyl ester and decarboxylase inhibitor with immediate release levodopa
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
YU36401A (sh) Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem
WO2000008007A3 (de) Cyclopentabenzofuran-derivate und ihre verwendung
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
MXPA05008843A (es) Sistema terapeutico que comprende amoxicilina y acido clavulanico.
WO2003105811A8 (en) PROGRESSIVE RELEASE COMPOSITIONS AND METHOD OF USE
GB9420748D0 (en) 1,5 benzodiazepine derivatives
ITFI910154A1 (it) Forma microcristallina dell'acido meclofenamico, metodo e formulazioni farmaceutiche
RU99108220A (ru) Способ лечения острого периода гипоталамического синдрома пубертатного периода
RU96113328A (ru) Способ торможения фиброзообразования

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties